The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy

Publisher： Karger

E-ISSN： 1661-7657|7|4|181-184

ISSN： 1661-7649

Source： Current Urology, Vol.7, Iss.4, 2014-08, pp. : 181-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates in the Management of Metastatic Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 5-11

Karger

Access to resources Recommend Favorite

Androgen-Independent Prostate Cancer Treated with Resection of the Solitary Metastatic Site

By  

Urologia Internationalis, Vol. 79, Iss. 4, 2007-11 ,pp. : 371-373

Karger

Access to resources Recommend Favorite

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3636-3643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study

By Kaji H.   Kuroki Y.   Murakawa Y.   Funakawa I.   Funasaka Y.   Kanda F.   Sugimoto T.  

Osteoporosis International, Vol. 21, Iss. 9, 2010-09 ,pp. : 1565-1571

Springer Publishing Company

Access to resources Recommend Favorite

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite